Skip to main content
. 2021 Apr 29;19(5):255. doi: 10.3390/md19050255

Figure 3.

Figure 3

Structures of (a) gageosatins A–C [90], (b) gageopeptides A–D [91], (c) gageomacrolactins A–C [89], (d) ieodoglucomides 1 and 2 [88], (e) glycosylated macrolactins A1 and B1 [94], (f) mollemycin A [98], and (g) thiomarinols A–G [99].